Afficher la couverture 'KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary | Torres, Vicente, E' en grand format
/5

0 avis

KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary

Archive ouverte

Torres, Vicente, E | Ahn, Curie | Barten, Thijs, R M | Brosnahan, Godela | Cadnapaphornchai, Melissa, A | Chapman, Arlene, B | Cornec-Le Gall, Emilie | Drenth, Joost, P H | Gansevoort, Ron, T | Harris, Peter, C | Harris, Tess | Horie, Shigeo | Liebau, Max, C | Liew, Michele | Mallett, Andrew, J | Mei, Changlin | Mekahli, Djalila | Odland, Dwight | Ong, Albert C.M. | Onuchic, Luiz, F | Pei, Null-, C | Perrone, Ronald, D | Rangan, Gopala, K | Rayner, Brian | Torra, Roser | Balk, Ethan, M | Gordon, Craig, E | Earley, Amy | Mustafa, Reem, A | Devuyst, Olivier

Edité par CCSD ; Nature Publishing Group -

International audience.

conducted. Limitations of the evidence are discussed. Research recommendations to address gaps in knowledge, and implications for policy and payment, are provided. The guideline targets a broad audience of healthcare providers, people living with ADPKD, and stakeholders involved in the various aspects of ADPKD care.

Suggestions

Du même auteur

Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Archive ouverte | Aymé, Ségolène | CCSD

International audience. Implementing access to diagnostic services in low-income regions Access to clinical expertise and genetic testing in resourcepoor countries may be limited. However, telemedicine can S Aymé et...

Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD) Consensus Workshop

Archive ouverte | Cho, Yeoungjee | CCSD

International audience. The omission of outcomes that are of relevance to patients, clinicians, and regulators across trials in autosomal dominant polycystic kidney disease (ADPKD) limits shared decision making. The...

Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review

Archive ouverte | Sautenet, Benedicte | CCSD

International audience. RATIONALE & OBJECTIVE: Trials in autosomal dominant polycystic kidney disease (ADPKD) have increased, but their impact on decision making has been limited. Because heterogeneity in reported o...

Chargement des enrichissements...